Zhejiang Sunflower Great Health Co., Ltd. (300111.SZ)

2,1900 -0,0700 (-3,10%) Al cierre: 03:04PM CST

Zhejiang Sunflower Great Health Co., Ltd.

Sanjiang Road
Paojiang Industrial Zone
Shaoxing 312071
China
86 575 8891 9159
https://www.sunowe.com

Sector(es): Technology
Sector: Solar
Empleados a tiempo completo: 322

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Huaxin Shi	GM & Non-Independent Director	N/A	N/A	1968
Mr. Wei Biao Pan	CFO, Deputy GM & Director	N/A	N/A	1970
Ms. Lan Li	Secretary of the Board	N/A	N/A	1983
Mr. Weijiang Ping	Deputy General Manager	N/A	N/A	1978
Mr. Jiangang Sun	Deputy General Manager	N/A	N/A	N/A

Los importes son a partir de y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en CNY.

Descripción

Zhejiang Sunflower Great Health Co., Ltd. engages in the research, development, production, and sale of anti-infectious, cardiovascular, digestive system and other drugs worldwide. It offers clarithromycin API and tablets, an anti-infective drug used for nasopharyngeal infection, lower respiratory tract infection, skin and soft tissue infection, acute otitis media, mycoplasma pneumoniae pneumonia, urethritis and cervicitis, as well as acute pharyngitis and acute tonsillitis; and azithromycin dispersible tablets for sinusitis, acute otitis media, acute bronchitis, acute exacerbation of chronic bronchitis, streptococcus pneumoniae, pneumonia, haemophilus influenzae, mycoplasma pneumoniae, urethritis, cervicitis and skin and soft tissue infection. The company also provides roxithromycin capsules to treat otitis, acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia caused by mycoplasma pneumoniae or chlamydia pneumoniae, urethritis, cervicitis, and skin and soft tissue infection. In addition, it offers lacidipine dispersible tablets for treatment of hypertension; and simvastatin tablets used for pediatric patients, cholesterol, Lipoprotein B, and triglycerides. Further, the company provides omeprazole sodium for injection, a digestive system drug, used as an alternative therapy for duodenal ulcer, gastric ulcer, reflux esophagitis, and Zollinger-Ellison syndrome; and famotidine for injection for treatment of peptic ulcer bleeding, acute gastric mucosal damage, and gastrointestinal bleeding caused by non-steroidal anti-inflammatory drugs. The company was formerly known as Zhejiang Sunflower Great Health Limited Liability Company and changed its name to Zhejiang Sunflower Great Health Co., Ltd. in December 2023. Zhejiang Sunflower Great Health Co., Ltd. was founded in 2005 and is headquartered in Shaoxing, China.

Gobierno corporativo

El ISS Governance QualityScore de Zhejiang Sunflower Great Health Co., Ltd., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.